Could cancer vaccines be next? New treatment cuts melanoma risk by nearly 50%
⚡ Quick Summary
A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer recurrence or death by nearly half.
📰 Related Articles
FACTBOX: What we know about foiled attack on military airfield in Rostov-on-Don
TASS
SIT moves Supreme Court to question officer in Gade Sai Krishna custodial death case
The HinduSouth Korea’s SK Hynix raises $26.5bn in record-breaking US IPO
Al JazeeraPosts falsely claim AI-generated video shows eruption of Indonesia's Anak Krakatau
AFP Fact Check
World Bank approves $375.9m to strengthen Pakistan's power transmission network
Dawn Pakistan